{
    "Trade/Device Name(s)": [
        "Liquichek Opiate Control",
        "LiquichekTM Opiate Control"
    ],
    "Submitter Information": "Bio-Rad Laboratories",
    "510(k) Number": "K093577",
    "Predicate Device Reference 510(k) Number(s)": [
        "K022707"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "DIF"
    ],
    "Summary Letter Date": "January 08, 2010",
    "Summary Letter Received Date": "January 22, 2010",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.3280"
    ],
    "Regulation Name(s)": [
        "Clinical toxicology control material"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Buprenorphine",
        "EDP",
        "Fentanyl",
        "Methadone",
        "6-Monoacetylmorphine (6-MAM, 6-AM)",
        "Oxycodone"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [
        ""
    ],
    "Instrument(s)/Platform(s)": [
        ""
    ],
    "Method(s)/Technology(ies)": [
        ""
    ],
    "Methodologies": [
        ""
    ],
    "Submission Type(s)": [
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for Bio-Rad Liquichek Opiate Control, a quality control urine for monitoring laboratory urine toxicology testing procedures for specified opiate analytes.",
    "Indications for Use Summary": "Liquichek Opiate Control is intended for use as a quality control urine to monitor the precision of laboratory urine toxicology testing procedures for the analytes listed in the package insert.",
    "fda_folder": "Toxicology"
}